| GP 500 Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| GP 500 600 mg-120 mg | tablet, extended release | oral | 1.0 each | OTC |
Johnstone still hoping for Toronto GP race in 2008 - National Post
"We're not going to be in May, because of the Indy 500. We're certainly not going to be before May, because of the weather. And we really can't race anytime ...
Wed Feb 27 19:08:51 -0500 2008
V8 Supercars fail to draw naming sponsor - Melbourne Herald Sun
Insurer ING is financing the headline F1 GP under a global deal, Vodafone and Fiat will support the Celebrity Challenge and Cleanevent will sponsor the ...
Sun Mar 02 09:21:46 -0500 2008
When size doesn’t matter (in business) - Kansas City Star
The product upgrade, called LaGarde eBusiness Solution, links LaGarde’s software products with Microsoft Dynamics GP, an accounting package designed to give ...
Tue Mar 04 08:59:16 -0500 2008
guaifenesin - A glyceryl guaiacolate with expectorant effects. Guaifenesin increases respiratory tract mucus secretions, acts as an irritant to gastric vagal receptors and recruits efferent parasympathetic reflexes that cause glandular exocytosis. This agent reduces the viscosity of mucus secretion by reducing adhesiveness and surface tension as well as increasing hydration of mucus. Guaifenesin promotes the efficiency of the mucociliary mechanism important in removing accumulated secretions from the upper and lower airway.
pseudoephedrine hydrochloride - The hydrochloride salt form of pseudoephedrine, a phenethylamine and an diastereomer of ephedrine with sympathomimetic property. Pseudoephedrine hydrochloride displaces norepinephrine from storage vesicles in presynaptic neurones, thereby releasing norepinephrine into the neuronal synapses where it stimulates primarily alpha-adrenergic receptors. It also has weak direct agonist activity at alpha- and beta- adrenergic receptors. Receptor stimulation results in vasoconstriction and decreases nasal and sinus congestion.